Mark Lomaga, BScPhm, PhD, MD, DABD, FRCPC

DermEdge Research
333 Lakeshore Road West, Suite 102
Mississauga, Ontario, Canada
L5H 1G9
905-274-9999


Specialty: Dermatology

Dr. Mark Lomaga, Dermatologist Specialist in Psoriasis

Research Interests: Acne, Actinic Keratosis, Atopic Dermatitis, Onychomycosis, Psoriasis, Psoriatic Arthritis, Rosacea

Dr. Mark Lomaga is a board certified Dermatologist and President of DermEdge Research in Mississauga, Ontario. At DermEdge Research Dr. Lomaga is one of the leading Investigators for clinical research trials involving investigational psoriasis treatments.

In addition to participating in clinical trials Dr. Lomaga maintains an active role as a dermatologist and lecturer at Women’s College Hospital in Toronto, Ontario. Dr. Lomaga is an active member of numerous associations including the Canadian Dermatology Association, Toronto Dermatological Society, Canadian Medical Association, and the American Board of Dermatology.

Dr. Lomaga’s doctoral work on TRAF-6, a protein which mediates signaling from the TNF receptor family was published in the Journal of Neuroscience.

 

Click to view Dr. Mark Lomaga's Publications


Reich K, Pinter A, Lacour JP, Ferrandiz C, Micali G, French LE, Lomaga M, Dutronc Y, Henneges C, Wilhelm S, Hartz S, Paul C, The IXORA-S investigators. Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase 3 study. Br J Dermatol 2017 May 19 [Epub ahead of print]. doi: 10.1111/bjd.15666

Lomaga MA, Walsh S.  Results of patch testing in patients with oral lichen planus.  J Cutan Med Surg 2009 Mar-Apr; 13(2):88-95.  PMID: 19298777

Lomaga MA, Walsh S.  A young man with fever and skin nodules. J Cutan Med Surg 2008 Nov-Dec; 12(6):299-301.  PMID: 19317953

Lomaga MA, Hayter C.  Priapism as a possible acute side effect of radical radiotherapy for prostate cancer.  Can J Urol 2004 Apr; 11(2):2205-2206.  PMID: 15182410

Lomaga MA, Henderson JT, Elia AJ, Robertson J, Noyce RS, Yeh WC, Mak TW.  Tumor necrosis factor receptor-associated factor 6 (TRAF6) deficiency results in exencephaly and is required for apoptosis within the developing CNS.  J Neurosci 2000 Oct; 20(19):7384-7393.  PMID: 11007897

Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kaufman S, van der Heiden A, Itie A, Wakeham A, Khoo W, Sasaki T, Cao Z, Penninger JM, Paige CJ, Lacey DL, Dunstan CR, Boyle WJ, Goeddel DV, Mak TW.  TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalling.  Genes Dev 1999 Apr; 13(8): 1015-1024.  PMID: 10215628

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login